1. Giant hepatocellular carcinoma with bone metastasis in a young adult, emerged from pigmented adenoma with beta-Catenin activation: A case report
- Author
-
Paula Döring, Lars Ivo Partecke, Sebastian Lünse, and Claus-Dieter Heidecke
- Subjects
Pathology ,medicine.medical_specialty ,Beta-catenin ,Hepatocellular carcinoma ,medicine.medical_treatment ,Case Report ,Malignant transformation ,03 medical and health sciences ,0302 clinical medicine ,Medicine ,Young adult ,biology ,business.industry ,Bone metastasis ,Hepatobiliary surgery ,Hepatocellular adenoma ,medicine.disease ,Rib resection ,digestive system diseases ,030220 oncology & carcinogenesis ,biology.protein ,030211 gastroenterology & hepatology ,Surgery ,Hepatectomy ,business - Abstract
Highlights • Hepatocellular carcinoma (HCC) is an extremely rare finding in young adult. • Giant HCCs are larger than 10 cm in diameter and mostly develop in non-cirrhotic livers. • Pigmented hepatocellular adenoma (HCA) with beta-catenin activation have an increased risk for malignant transformation. • Surgical resection is the only curative treatment with best long-term outcome. • Molecular classification of HCAs is a useful tool for risk assessment of malignant transformation., Introduction Hepatocellular carcinomas (HCC) that are very large in size are a very rare finding in young adult. The malignant transformation of a pigmented hepatocellular adenoma (HCA) with beta-Catenin activation is a possible cause for appearance of HCC. Presentation of case We present the case of a 33-year-old male with a huge HCC with bone metastasis, emerged from pigmented HCA with beta-Catenin activation. As a two-stage surgical procedure, a left hepatectomy followed by a partial rib resection was performed. Discussion Giant hepatocellular carcinomas mostly develop in non-cirrhotic livers and at time of diagnosis an extrahepatic spread occurs in up to 15%. In the present case, the progression from a benign HCA to malignant HCC was documented, as a unique finding. Surgical resection is the only curative treatment and was successfully performed in this case. Conclusion Hepatobiliary surgery with resection of metastases is the treatment with best long-term survival for patients with huge HCC. Molecular characterization as well as pigmentation analysis is useful tools for risk assessment of HCA.
- Published
- 2017
- Full Text
- View/download PDF